These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28133088)

  • 1. [Liver Metastases from Pancreatic Neuroendocrine Tumor(P-NET)Treated with Surgery and Chemotherapy].
    Ueshima S; Oka Y; Hayashida H; Higaki Y; Yoshioka S; Okada K; Nezu R
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1653-1655. PubMed ID: 28133088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant Capecitabine/Temozolomide for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors.
    Squires MH; Worth PJ; Konda B; Shah MH; Dillhoff ME; Abdel-Misih S; Norton JA; Visser BC; Dua M; Pawlik TM; Schmidt CR; Poultsides G; Cloyd JM
    Pancreas; 2020 Mar; 49(3):355-360. PubMed ID: 32132509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.
    Sugimoto M; Takagi T; Hikichi T; Suzuki R; Watanabe K; Nakamura J; Kikuchi H; Konno N; Waragai Y; Asama H; Takasumi M; Watanabe H; Obara K; Ohira H
    World J Gastroenterol; 2015 Jul; 21(26):8118-24. PubMed ID: 26185384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases.
    Cloyd JM; Omichi K; Mizuno T; Kawaguchi Y; Tzeng CD; Conrad C; Chun YS; Aloia TA; Katz MHG; Lee JE; Halperin D; Yao J; Vauthey JN; Dasari A
    Ann Surg Oncol; 2018 Jun; 25(6):1709-1715. PubMed ID: 29626307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. A propensity score survival evaluation.
    Bertani E; Fazio N; Radice D; Zardini C; Spinoglio G; Chiappa A; Ribero D; Biffi R; Partelli S; Falconi M
    Eur J Surg Oncol; 2017 Feb; 43(2):372-379. PubMed ID: 27742480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pancreatic Cancer with Liver Metastasis Treated with Radical Surgery after Chemotherapy].
    Katsura Y; Takeda Y; Ohmura Y; Sakamoto T; Inatome J; Naito A; Murakami K; Kagawa Y; Takeno A; Egawa C; Kato T; Tamura S
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1975-1977. PubMed ID: 28133194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine tumor G3: a pancreatic well-differentiated neuroendocrine tumor with a high proliferative rate.
    Tanaka H; Matsusaki S; Baba Y; Isono Y; Kumazawa H; Sase T; Okano H; Saito T; Mukai K; Kaneko H
    Clin J Gastroenterol; 2015 Dec; 8(6):414-20. PubMed ID: 26439620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Curatively resected case of non-functioning pancreatic neuroendocrine carcinoma with multiple liver metastases after downstaging with S-1 monotherapy].
    Sato I; Ueda N; Kinoshita E; Minato H; Ohno K; Nakaya N; Shimasaki T; Nakajima H; Kosaka T; Motoo Y
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1341-4. PubMed ID: 20647723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment Strategy for Non-Functional Pancreatic Neuroendocrine Tumors (P-NETs) at Kurume University Hospital].
    Kawashima Y; Ishikawa H; Hisaka T; Okuda K; Akagi Y
    Gan To Kagaku Ryoho; 2016 Jan; 43(1):107-10. PubMed ID: 26809536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
    Auernhammer CJ; Jauch KW; Hoffmann JN
    Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Simultaneous laparoscopic resection of a pancreatic neuroendocrine tumour and liver metastasis].
    Hernández CM; Campos RR; Conesa AL; Parrilla P
    Cir Esp; 2011 Jan; 89(1):61-3. PubMed ID: 20510399
    [No Abstract]   [Full Text] [Related]  

  • 12. Metastases of pancreatic neuroendocrine tumor to the liver as extremely rare indication for liver transplantation in children. Case report and review of the literature.
    Ismail H; Broniszczak D; Markiewicz-Kijewska M; Ciopiński M; Teisseyre J; Kluge P; Dembowska-Bagińska B; Kościesza A; Socha P; Kaliciński P
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):e33-7. PubMed ID: 26850362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two Cases of Pancreatic Neuroendocrine Tumor with Liver Metastases Successfully Treated with Multidisciplinary Therapy including Multiple Surgical Resections].
    Akiyama T; Yoshitomi H; Shida T; Shimizu H; Ohtsuka M; Kato A; Furukawa K; Takayashiki T; Kuboki S; Takano S; Okamura D; Suzuki D; Sakai N; Kagawa S; Miyazaki M
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2397-9. PubMed ID: 26805376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A Case of Pancreatic Head Neuroendocrine Tumor with Multiple Liver Metastases Successfully Treated with Multimodality Therapy IncludingRepeat Hepatectomy].
    Inaba Y; Hongo M; Ninomiya R; Nakazawa A; Hashimoto D
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):1994-1996. PubMed ID: 30692422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful management of multiple liver metastases from pancreatic neuroendocrine tumor by hepatic arterial administration of cisplatin powder.
    Igarashi H; Ito T; Yoshinaga M; Kodama M; Hayashi H; Sakai H; Kawabe K; Takayanagi R
    Pancreas; 2007 Oct; 35(3):288-90. PubMed ID: 17895855
    [No Abstract]   [Full Text] [Related]  

  • 16. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
    Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
    Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal therapy with aggressive hepatectomy, everolimus, and octreotide for metastatic pancreatic neuroendocrine neoplasm enables 10-year survival.
    Yumoto S; Nakagawa S; Hayashi H; Ogawa D; Shiraishi Y; Sato H; Matsumoto T; Imai K; Yamashita YI; Baba H
    Clin J Gastroenterol; 2022 Dec; 15(6):1136-1144. PubMed ID: 36038805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal treatment of neuroendocrine tumors of the pancreas and the ampulla of Vater.
    Mantke R; Manger T; Schulz HU; Ridwelski K; Pross M; Günther T; Lippert H
    Dig Surg; 1999; 16(2):145-51. PubMed ID: 10207242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous metastasis as an initial presentation of a non-functioning pancreatic neuroendocrine tumor.
    Shin WY; Lee KY; Ahn SI; Park SY; Park KM
    World J Gastroenterol; 2015 Sep; 21(33):9822-6. PubMed ID: 26361431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A Case of Pancreatic Neuroendocrine Tumor(p-NET)with Long-Term Survival with Multidisciplinary Treatment].
    Katsura Y; Takeda Y; Ohmura Y; Sakamoto T; Shinke G; Katsuyama S; Kawai K; Kitahara T; Hiraki M; Murakami K; Kagawa Y; Masuzawa T; Takeno A; Hata T; Murata K
    Gan To Kagaku Ryoho; 2021 Mar; 48(3):394-396. PubMed ID: 33790166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.